ACXA

Accurexa Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 2/16/2017
Contact Info
  • 113 Barksdale
  • Newark, DE 19711

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 OTCQB Certification
CIK 0001562107
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 2012
Employees 5 a/o Jun 05, 2013
Company Officers/Contacts
Bryan Lee CEO
Stefan Moll CFO
Company Directors
William Callahan
Oliver Jackson
Service Providers
Accounting/Auditing Firm
Seale & Beers, CPAs, LLC
8250 W. Charleston Blvd
Suite 100
Las Vegas, NV, 89117
United States
 
Securities Counsel
Frank J. Hariton, Esq.
1065 Dobbs Ferry Road
White Plains, NY, 10607
United States
 
Investor Relations Firm
The Ruth Group
757 Third Avenue
22nd Floor
New York, NY, 10017
United States
 
Company History
  • Formerly=Cyto Wave Technologies Inc. until 8-2014
ACXA Security Details
Share Structure
Market Value1 $1,546,620 a/o Mar 29, 2017
Authorized Shares 20,000,000 a/o Aug 12, 2016
Outstanding Shares 9,198,954 a/o Nov 04, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 1,557,000 a/o Apr 12, 2016
Par Value 0.0001
Transfer Agent(s) Verified by Transfer Agent
Nevada Agency and Transfer Company
Shareholders
Shareholders of Record 60 a/o Mar 25, 2015
Short Selling Data
Short Interest 0 (-100%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security